Suppr超能文献

内源性表达人 CD83 可减轻人源化转基因小鼠的 EAE 症状并增加调节性 T 细胞的活性。

Endogenous Expression of the Human CD83 Attenuates EAE Symptoms in Humanized Transgenic Mice and Increases the Activity of Regulatory T Cells.

机构信息

Department of Immune Modulation, Universitätsklinikum Erlangen, Erlangen, Germany.

Transgenic Core Facility, Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.

出版信息

Front Immunol. 2019 Jun 25;10:1442. doi: 10.3389/fimmu.2019.01442. eCollection 2019.

Abstract

The CD83 is a type I membrane protein and part of the immunoglobulin superfamily of receptors. CD83 is involved in the regulation of antigen presentation and dendritic cell dependent allogeneic T cell proliferation. A soluble form of CD83 inhibits dendritic cell maturation and function. Furthermore, CD83 is expressed on activated B cells, T cells, and in particular on regulatory T cells. Previous studies on murine CD83 demonstrated this molecule to be involved in several immune-regulatory processes, comprising that CD83 plays a key role in the development und function of different immune cells. In order to get further insights into the function of the human CD83 and to provide preclinical tools to guide the function of CD83/sCD83 for therapeutic purposes we generated Bacterial Artificial Chromosomes (BAC) transgenic mice. BACs are excellent tools for manipulating large DNA fragments and are utilized to engineer transgenic mice by pronuclear injection. Two different founders of BAC transgenic mice expressing human CD83 (BAC-hCD83 mice) were generated and were examined for the hCD83 expression on different immune cells as well as both the and role of human CD83 (hCD83) in health and disease. Here, we found the hCD83 molecule to be present on activated DCs, B cells and subtypes of CD4 T cells. CD8 T cells, on the other hand, showed almost no hCD83 expression. To address the function of hCD83, we performed mixed lymphocyte reactions (MLR) as well as suppression assays and we used the model of experimental autoimmune encephalomyelitis (EAE) comparing wild-type and hCD83-BAC mice. Results herein showed a clearly diminished capacity of hCD83-BAC-derived T cells to proliferate accompanied by an enhanced activation and suppressive activity of hCD83-BAC-derived Tregs. Furthermore, hCD83-BAC mice were found to recover faster from EAE-associated symptoms than wild-type mice, encouraging the relevance also of the hCD83 as a key molecule for the regulatory phenotype of Tregs and .

摘要

CD83 是一种 I 型跨膜蛋白,属于免疫球蛋白超家族受体。CD83 参与抗原呈递和树突状细胞依赖性同种异体 T 细胞增殖的调节。可溶性 CD83 形式抑制树突状细胞成熟和功能。此外,CD83 表达于活化的 B 细胞、T 细胞,特别是调节性 T 细胞上。先前关于鼠 CD83 的研究表明,该分子参与了几个免疫调节过程,包括 CD83 在不同免疫细胞的发育和功能中发挥关键作用。为了深入了解人类 CD83 的功能,并提供临床前工具来指导 CD83/sCD83 的功能用于治疗目的,我们生成了细菌人工染色体(BAC)转基因小鼠。BAC 是操纵大片段 DNA 的优秀工具,并通过原核注射用于工程转基因小鼠。生成了表达人类 CD83 的两种不同 BAC 转基因小鼠(BAC-hCD83 小鼠)的创始者,并检查了不同免疫细胞上 hCD83 的表达以及人类 CD83(hCD83)在健康和疾病中的 和 作用。在这里,我们发现 hCD83 分子存在于活化的 DC、B 细胞和 CD4 T 细胞亚群上。另一方面,CD8 T 细胞几乎没有 hCD83 表达。为了解 hCD83 的功能,我们进行了混合淋巴细胞反应(MLR)以及抑制试验,并使用实验性自身免疫性脑脊髓炎(EAE)模型比较了野生型和 hCD83-BAC 小鼠。结果显示,hCD83-BAC 衍生的 T 细胞增殖能力明显降低,同时 hCD83-BAC 衍生的 Tregs 激活和抑制活性增强。此外,与野生型小鼠相比,hCD83-BAC 小鼠从 EAE 相关症状中恢复得更快,这也鼓励 hCD83 作为 Tregs 和 的调节表型的关键分子的相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3322/6603205/ffb918979507/fimmu-10-01442-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验